1. In Vivo
  2. >>Innovation

How Boehringer Ingelheim Deepened Its Digital Transformation

 
• By David Wild

While many pharma companies have integrated digital tools like cloud services into their operations, some are later adopters. Boehringer Ingelheim is one of the most recent companies to announce a move to a cloud-based R&D platform as part of the company’s commitment to digital transformation. For those still considering how to go about the shift to digital, rolling things out in the right order is one important factor, an EY expert tells In Vivo.          

Cloud-Based Services Have Become The Cornerstone of Digital Transformation • Source: Shutterstock

Cloud-based operations are increasingly being seen as the cornerstone of digital transformation in biopharma, linking growing amounts of data across an organization. Cloud-based drug development platforms received added attention during the early stages of the COVID-19 pandemic after Moderna, Inc. noted that part of the reason the company was able to bring its mRNA vaccine into clinical trials within only 42 days of initially sequencing the virus was because cloud-based computing and storage infrastructure allowed it to more efficiently analyze and design mRNA sequences.

In PwC’s Digital IQ 2020 survey, 60% of pharma executives said they already made investments in cloud services to support their digital transformation, or were developing plans to do so....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation

More from In Vivo